Literature DB >> 10687969

Clinical and pathological characteristics of micropapillary transitional cell carcinoma: a highly aggressive variant.

J K Maranchie1, B T Bouyounes, P L Zhang, M A O'Donnell, I C Summerhayes, W C DeWolf.   

Abstract

PURPOSE: We present preliminary clinical, histochemical and molecular findings for 5 patients with micropapillary transitional cell carcinoma of the bladder, a rare histological variant not widely recognized in the urological literature.
MATERIALS AND METHODS: The 5 patients were prospectively identified. In 3 cases immunohistochemical staining for expression of CD31, p53, E-cadherin, and alpha, beta and gamma-catenin was performed on paraffin embedded tissue. Sequencing was used to identify point mutations in exons 5 to 9 of p53, and exons 1 and 2 of H-ras.
RESULTS: Of the patients 2 died within 1 year of presentation to our institution with rapid local extension along the bladder serosal surface and ureteral sheaths. Another patient had progression to invasive disease within 22 months. In the 3 cases with immunohistochemical staining p53 was negative, despite positive staining of nonmicropapillary transitional cell carcinoma within the same specimen. Stains for the angiotrophic marker CD31 were negative. In all 3 cases normal membrane associated alpha, beta and gamma-catenin expression was present. Examination of p53 sequences revealed a single point mutation in exon 8 of 1 case. In 2 cases different mutations in exon 1 of H-ras were noted.
CONCLUSIONS: Micropapillary transitional cell carcinoma is a rare and highly aggressive variant. Paradoxically, our study demonstrated no significant p53 abnormalities. The lacunar histological pattern did not appear to represent invasion of vascular spaces. Rather, these tumors seemed to have the ability to disrupt and replace the normal stromal matrix to achieve rapid nonendothelial extension. Thus, micropapillary histology may predict a lesser likelihood of surgical cure.

Entities:  

Mesh:

Year:  2000        PMID: 10687969

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Clot retention and spontaneous rupture with secondary pneumatosis of bladder wall following routine cystoscopy.

Authors:  S Kravchick; S Cytron; L Lobik; A Altshuler; Y Kravchenko; D Ben-Dor
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 2.  Neoadjuvant chemotherapy for bladder cancer.

Authors:  Peter C Black; Gordon A Brown; H Barton Grossman; Colin P Dinney
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

3.  Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.

Authors:  Massimiliano Spaliviero; Guido Dalbagni; Bernard H Bochner; Bing Ying Poon; Hongying Huang; Hikmat A Al-Ahmadie; Timothy F Donahue; Jennifer M Taylor; Joshua J Meeks; Daniel D Sjoberg; S Machele Donat; Victor E Reuter; Harry W Herr
Journal:  J Urol       Date:  2014-03-03       Impact factor: 7.450

Review 4.  Micropapillary bladder cancer: current treatment patterns and review of the literature.

Authors:  Daniel L Willis; Thomas W Flaig; Donna E Hansel; Matthew I Milowsky; Robert L Grubb; Hikmat A Al-Ahmadie; Elizabeth R Plimack; Theresa M Koppie; David J McConkey; Colin P Dinney; Vanessa A Hoffman; Michael J Droller; Edward Messing; Ashish M Kamat
Journal:  Urol Oncol       Date:  2014-06-13       Impact factor: 3.498

5.  Immunohistochemical analysis of invasive micropapillary carcinoma pattern in four cases of gastric cancer.

Authors:  Yuji Ohtsuki; Naoto Kuroda; Shigeru Yunoki; Shinzo Murakami; Yuji Mizukami; Yuhei Okada; Mitsuko Iguchi; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2013-03-09       Impact factor: 2.309

6.  KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon.

Authors:  Yuji Ohtsuki; Naoto Kuroda; Tatsuo Umeoka; Ryohei Watanabe; Kenji Ochi; Yuhei Okada; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

7.  Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.

Authors:  Alexandra Masson-Lecomte; Evanguelos Xylinas; Morgane Bouquot; Mathilde Sibony; Yves Allory; Eva Comperat; Marc Zerbib; Alexandre de la Taille; Morgan Rouprêt
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

8.  Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.

Authors:  Yuji Ohtsuki; Kenji Ochi; Yuhei Okada; Miyuki Kato; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

Review 9.  Characteristics and clinical significance of histological variants of bladder cancer.

Authors:  Marco Moschini; David D'Andrea; Stephan Korn; Yasin Irmak; Francesco Soria; Eva Compérat; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

10.  Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database.

Authors:  Srinivas Vourganti; Andrew Harbin; Eric A Singer; Brian Shuch; Adam R Metwalli; Piyush K Agarwal
Journal:  J Cancer       Date:  2013-05-06       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.